2015 Clinic Provider Specialization 
The Medical Futurist
JUNE 17, 2025
Artificial intelligence Already, dentists employ software to get insights into clinical decision-making, but AI is changing the face of dentistry, just like it is in many other fields. Smart toothbrush While AI helps dental professionals provide better treatments, smart toothbrushes enable all of us to take better care of our teeth.
The Clinical Problem Solvers
SEPTEMBER 19, 2024
Michelle Ogunwole, MD, PhD, an internist and social epidemiologist who specializes in the care of women with chronic medical conditions and racial disparities in maternal health outcomes, and Dr. Caroline Sloan, MD, a general internist whose research focuses on how financial considerations are imbued into medical decision-making. Zakaria, S.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Louisville Lectures
OCTOBER 5, 2018
These will focus on delivering just-in-time algorithms, practical clinical knowledge and board tips on high-yield topics. These lectures will be provided by the University of Louisville Internal Medicine residents. Disclaimers ©2015 LouisvilleLectures.org Visit here. For more information, see our citation page.
The Medical Futurist
JUNE 21, 2025
In 2015, surgeons in Manchester, UK have performed the first bionic eye implant for an AMD patient using Second Sight’s innovation. Researchers say that the implant cannot provide any highly detailed vision – but it can help patients detect distinct patterns such as door frames and shapes. That must have been truly amazing!
The Clinical Problem Solvers
MARCH 14, 2025
Dr. Benton mentors clinical and research physicians, fellows, and postdoctoral trainees. Clinically, he cares for youth and families through the Department of Psychiatry & Behavioral Sciences and the new Division of Addiction Medicine at Boston Children’s Hospital. Child and Adolescent Psychiatric Clinics of North America.
FDA Law Blog
SEPTEMBER 30, 2022
Billy Dunn, the Director of CDER’s Office of Neuroscience, at the September 7, 2022 meeting of the Peripheral and Central Nervous System Drugs Advisory Committee, applying the statutory standard in approval decisions in these clinical contexts warrants the “broadest possible” flexibility. emphasis added).
FDA Law Blog
JUNE 23, 2021
For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. Over the years, this function expanded to cancer (renamed the Office of AIDS and Special Health Issues) and, ultimately, all serious and life-threatening diseases (dropping the AIDS nomenclature).
Expert insights. Personalized for you.
126 
Let's personalize your content